Consolidated Statements of Operations - USD ($) $ in Thousands		12 Months Ended
	Mar. 22, 2022	Dec. 31, 2022	Dec. 31, 2021
Revenues		$ 19,418	$ 15,995
Cost of Revenues		5,489	4,374
Gross Profit		13,929	11,621
Operating Expenses
Research and development		17,661	14,121
Sales and marketing		8,872	8,261
General and administrative		26,060	41,478
Acquisition-related costs		426	1,248
Impairment of goodwill and intangibles		12,199	14,789
Amortization of intangibles		5,411	4,467
Total Operating Expenses		70,629	84,364
Loss from Operations		(56,700)	(72,743)
Other Income (Expense)
Interest (expense)/income, net		(673)	1,183
Loss on exchange of debt for equity		0	(30)
Benefit for valuation allowance on related party loan - held for sale		0	7,345
Other income/( expense)		692	(47)
Gain on related party loan - held for sale		0	49,817
Unrealized loss on equity securities		(7,904)	(57,067)
Unrealized loss on equity method investment		(1,784)	0
Total Other Income (Expense)		(9,669)	1,201
Net Loss, before tax		(66,369)	(71,542)
Income tax benefit		65	1,412
Net Loss		(66,304)	(70,130)
Net Expense Attributable to Non-controlling Interest		(2,910)	(975)
Net Loss Attributable to Stockholders of Inpixon		(63,394)	(69,155)
Deemed dividend for the modification related to Series 8 Preferred Stock	$ 2,600
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock	$ 1,500
Net Loss Attributable to Common Stockholders, Basic		(79,570)	(77,316)
Net Loss Attributable to Common Stockholders, Diluted		$ (79,570)	$ (77,316)
Net Income (Loss) Per Share
Net Loss Per Share - Basic (in usd per share)		$ (34.12)	$ (51.18)
Net Loss Per Share - Diluted (in usd per share)		$ (34.12)	$ (51.18)
Weighted Average Shares Outstanding
Basic (in shares)		2,332,041	1,510,678
Diluted (in shares)		2,332,041	1,510,678
Series 7 Convertible Preferred Stock
Other Income (Expense)
Accretion of preferred Stock		$ (4,555)	$ (8,161)
Series 8 Preferred Stock
Other Income (Expense)
Accretion of preferred Stock		(13,090)	0
Deemed dividend for the modification related to Series 8 Preferred Stock		(2,627)	0
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock		1,469	0
Amortization premium- modification related to Series 8 Preferred Stock		$ 2,627	$ 0